Zobrazeno 1 - 10
of 578
pro vyhledávání: '"T, Yamori"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8)
Glyoxalase I (GLO1) is an enzyme that plays a role in the detoxification of methylglyoxal, a side-product of glycolysis. We previously reported that GLO1 was a resistant factor to antitumor agent-induced apoptosis, and that S-p-bromobenzylglutathione
Autor:
Y, Komatsu, K Y, Tomizaki, M, Tsukamoto, T, Kato, N, Nishino, S, Sato, T, Yamori, T, Tsuruo, R, Furumai, M, Yoshida, S, Horinouchi, H, Hayashi
Publikováno v:
Cancer research. 61(11)
Cyclic hydroxamic-acid-containing peptide 1 (CHAP1), designed as a hybrid of trichostatin A and trapoxin, is a lead compound for the development of potent inhibitors of histone deacetylase (HDAC). In this study, we synthesized a series of CHAP deriva
Autor:
T, Oyama, Y, Miyoshi, K, Koyama, H, Nakagawa, T, Yamori, T, Ito, H, Matsuda, H, Arakawa, Y, Nakamura
Publikováno v:
Genes, chromosomescancer. 29(1)
Metastasis, a major factor contributing to poor prognosis of cancer patients, is caused by a complex series of events that involve many genes. To investigate this process, we analyzed by differential display three cell lines that had been established
Autor:
T, Yamori, T, Ando, S, Uehara, M, Ono, M, Kawano, I, Saiki, M, Naito, Y, Hayakawa, T, Tsuruo, Y, Sugimoto, K, Kiyomiya, T, Majima
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 27
Autor:
T, Yamori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 27
Publikováno v:
Anticancer research. 20(1A)
We examined the anti-tumor effect of 5-S-GAD, a novel potent inhibitor of protein tyrosine kinases, isolated from the flesh fly in order to investigate the potential use of this compound as an anti-tumor agent.In vitro growth inhibition was evaluated
Autor:
T, Yamori, A, Matsunaga, S, Sato, K, Yamazaki, A, Komi, K, Ishizu, I, Mita, H, Edatsugi, Y, Matsuba, K, Takezawa, O, Nakanishi, H, Kohno, Y, Nakajima, H, Komatsu, T, Andoh, T, Tsuruo
Publikováno v:
Cancer research. 59(16)
We synthesized a novel anticancer agent MS-247 (2-[[N-[1-methyl-2-[5-[N-[4-[N,N-bis(2-chloroethyl) amino] phenyl]] carbamoyl]-1H-benzimidazol-2-yl] pyrrol-4-yl] carbamoyl] ethyldimethylsulfonium di-p-toluenesulfonate) that has a netropsin-like moiety
Publikováno v:
Cancer research. 59(16)
To facilitate the search for candidate telomerase inhibitors, we exploited the database of the disease-oriented screening program (DOS) available in our facility by using COMPARE analysis. In primary and arbitrary screening, we were able to identify